Discover 3,133 paid clinical trials in Houston, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Houston is home to world-renowned medical centers offering a variety of trials targeting conditions such as cancer, heart disease, diabetes, and Alzheimer’s. Healthy volunteers interested in paid research opportunities, as well as individuals in need of trials for specific conditions, can participate in these studies to access cutting-edge treatments and contribute to the development of innovative therapies.
Filter
2
Filter results
Results: 3,133
A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas
for
Bladder Cancer, Squamous Cell Carcinoma of the Lung,
Location: Houston TX, Nashville TN, Atlanta GA, Durham NC,
Sponsor: EvolveImmune United, Inc
Sex: All
Age: 18+
Code: NCT07217171
Phase 1, Recruiting
A Phase II Study of the Combination of Azacitidine and Pembrolizumab for Patients Relapsed/Refractory Hodgkin's Lymphoma
for
Hodgkin's Lymphoma
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 1+
Code: NCT05355051
Phase 2, Recruiting
First-in-Human Trial of VBC101 in Participants With Advanced Solid Tumor Malignancies
for
Participants With Advanced Solid Tumor Malignancies
Location: Houston TX, San Antonio TX, Grand Rapids MI,
Sponsor: VelaVigo Bio Inc
Sex: All
Age: 18+
Code: NCT07136779
Phase 1, Phase 2, Recruiting
Social and Environmental Determinants of Breast Cancer Survivorship: the Black Breast Cancer Survivor's Intervention (BBCSI)
for
Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: Female
Age: 18+
Code: NCT06885203
Recruiting
A Study to Compare the Efficacy of Nivolumab and Relatlimab Plus Chemotherapy vs Pembrolizumab Plus Chemotherapy for Stage IV/Recurrent Non-squamous Non-small Cell Lung Cancer With PD-L1 Expression ≥ 1%
A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib
for
Acute Myeloid Leukemia
Location: Houston TX, Baltimore MD, New York NY, Boston MA
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
for
Geographic Atrophy
Location: Bellaire TX, Austin TX, San Antonio TX, Dallas TX,
Sponsor: Sanofi
Sex: All
Age: 60+
Code: NCT07215234
Phase 1, Phase 2, Recruiting
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
for
Cataract, Glaucoma, Ocular Hypertension
Location: Houston TX
Sponsor: SpyGlass Pharma, Inc.
Sex: All
Age: 22+
Code: NCT07218783
Phase 3, Recruiting
Studying Health Outcomes After Treatment in Patients With Retinoblastoma
for
Retinoblastoma, Cancer Survivor, Biological Sibling,
Location: Houston TX, Nashville TN, St Louis MO, Cincinnati OH,
Sponsor: Vanderbilt-Ingram Cancer Center
Sex: All
Age: 0+
Code: NCT03932786
Recruiting
Evaluating BL-M14D1 in Subjects With Locally Advanced or Metastatic Small Cell Lung Cancer and Neuroendocrine Tumors
for
Small Cell Lung Cancer Metastatic or Locally Advanced,
Location: Houston TX, San Antonio TX, Dallas TX, New Orleans LA,
Sponsor: SystImmune Inc.
Sex: All
Age: 18+
Code: NCT07080242
Phase 1, Recruiting
Study of Naxitamab and Sacituzumab Govitecan in Patients With Metastatic Triple-negative Breast Cancer (TNBC)
for
Metastatic Triple-Negative Breast Cancer
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 18+
Code: NCT07011654
Phase 1, Phase 2, Recruiting
Safety and Immunological Effect of Pembrolizumab in Resectable or Borderline Resectable Pancreatic Cancer
for
Pancreatic Cancer
Location: Houston TX, Phoenix AZ, Charlottesville VA, Hartford CT,
Sponsor: Craig L Slingluff, Jr
Sex: All
Age: 18+
Code: NCT02305186
Phase 1, Phase 2, Recruiting
Treating Contact Lens Discomfort With Varenicline Solution Nasal Spray 0.03mg